Table 2.
Authors | Year | Type of Biosensor | Chemical Process | Experiment | Fluid | Biomarker | LODs |
---|---|---|---|---|---|---|---|
Ali et al. [43] | 2007 | poly (anilineboronic acid)/carbon nanotube composit | Dopamine oxidation | In vitro | Blood | Dopamine | - |
Bai and Jiang [44] | 2013 | Copper sulfide-decorated reduced graphene oxide composites | CuS/RGO composite-based reaction | In vitro | - | H2O2 | - |
Xu et al. [35] | 2015 | Cysteamine-graphene modified gold electrode nanocomposites | Carboxylic acid-induced covalent attachment | In vitro | Serum | α-synuclein | 1.2 pM |
Wang et al. [45] | 2015 | Gold Fe3O4 Platinum Graphene-based nanocomposites |
Catalytic reaction of Pt RGO/AuFe3O4-GCE | In vitro | Normal and tumor cells | H2O2 | 0.1 μM |
Oh et al. [46] | 2017 | Organic field-effect-transistor-type nonenzymatic biosensor | Dopamine oxidation | In vivo | ISF | L-Dopa | 10 pM |
Goud et al. [15] | 2019 | Orthogonal electrochemical/ biocatalytic hollow MN |
Dopamine oxidation | In vivo/In vitro | ISF | L-Dopa | - |
Nguyen et al. [47] | 2019 | Platinum-based nanocomposite | Glutamate oxidation | In vitro | Spinal cord sample | Glutamate | 0.2–0.5 μM |
Aziz et al. 2019 [48] | 2019 | LDHs and graphene-based nanocomposite |
Dopamine oxidation | In vitro | Living cells | Dopamine | 2.0 nM |
Dong et al. [49] | 2020 | 5-(1,2-dithiolan-3-yl)-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) pent-anamide | One-step amide reaction | In vitro | Blood | H2O2 | 0.02 μM |
Chang et al. [50] | 2021 | Nanobiosensor integrated with solid-phase microextractiontechnique | Dopamine oxidation | In vitro | Cytoplasm of single living cell | Dopamine | 10 pM |
Moon et al. [25] | 2021 | Wearable electrochemical platform | L-Dopa oxidation | In vivo/In vitro | Sweat/Blood | L-Dopa | - |
Shi et al. [51] | 2021 | N-doped carbon nanorods and Au nanoparticles based biosensor | Dopamine oxidation | In vivo | Serum | Dopamine | - |
Kudur-Jayaprakash et al. [40] | 2021 | Cetyl pyridinium bromide (CPB) modified carbon paste electrode (CPBMCPE) biosensor | Dopamine/Uric Acid-Voltammetric oxidation | In vivo | Urine | Dopamine/Uric Acid | 38–42 μM |
LOD: limit of detection.